Our Purpose
Recapturing what the brain never forgot
Communication is a fundamental human need. For people living with motor conditions caused by ALS, spinal cord injury, or stroke, the loss of speech and motor functionality can isolate them from the world.
At Paradromics, we're building a future where motor impairment no longer means silence or disconnection. Our Connexus Brain-Computer Interface (BCI) is designed to transform neural signals into communication – synthesized speech, text, and computer control – at speeds that enable natural conversations.
Introducing Connexus BCI
Designed for data rate, safety, and durability
This is advanced neurotechnology built on 30 years of brain-machine interface research, refined through relentless engineering, and designed for long-term medical use.
This is Connexus BCI.
The data difference
421 microelectrodes, each smaller than a human hair, reach 1.5mm below the brain's surface to capture signals from individual neurons as they fire. This level of resolution enables a clear picture of the user's intended action. In pre-clinical testing, the Connexus BCI demonstrated an information transfer rate exceeding 200 bits per second (bps) – 20x faster than existing BCIs.
Safety by design
Every component within the Connexus BCI was thoughtfully selected to avoid risk. It uses medically proven materials and packaging technology and is implanted using surgical steps that are already familiar to nearly every neurosurgeon. The Connexus BCI is designed to deliver the safest possible path from development to patient use.
Built to last
The Connexus BCI is a fully internalized, fully wireless system. It is hermetically sealed against moisture to protect it from the body. Every design choice prioritizes longevity because every BCI user deserves a device that is engineered to last as long as needed. The goal is stable neural recordings for more than 10 years.
how it works
From neural signals to natural speech
Surgical placement
neural signal capture
wireless transmission
ai-powered translation
Clinical Study Begins 2026
Advancing the science of speech decoding and restoration
The Connect-One Clinical Study is testing the Connexus BCI's capabilities to restore communication for people who can no longer speak.
Participants can help shape a future where they – and countless others – can communicate, use a computer, and live more independently.